The isolated perfused hearts of rabbits previously subjected to in vivo left ventricular myocardial infarction (LVMI) show a 5-10-fold increase inf-Met-Leu-Phe (FMLP) and bradykinin (BK)-stimulated eicosanoid metabolite production relative to noninfarcted hearts. This exaggerated arachidonate metabolism has been shown to occur primarily in the cardiac atria, a site remote from the zone of injury and to be associated with a 10-15-fold increase in atrial FMLP receptor number in the absence of atrial inflammation. All of these changes were temporally related to leukocyte infiltration into the infarct zone. To determine whether invading leukocytes mediate these responses, acute inflammatory cell influx was suppressed either by inducing leukopenia with nitrogen mustard or by administration of BW-755C, a mixed cyclooxygenase-lipoxygenase inhibitor. Both pharmacological manipulations resulted in a decrease in inflammatory cells in the infarct zone and a marked suppression (50-70%) of ex vivo agonist-stimulated eicosanoid metabolite production from perfused hearts and isolated atria.
Introduction
The isolated buffer perfused hearts of rabbits previously subjected to in vivo left ventricular myocardial infarction (LVMI)' demonstrate a 5-10-foid increase in the production Address reprint requests to Dr. Needleman, Department of Pharmacology, Washington University School of Medicine, St. Louis, MO 63110.
Receivedfor publication 22 February 1988 and in revisedform 25 August 1988. 1 . Abbreviations used in this paper: BK, bradykinin; LT, leukotriene; LVMI, left ventricular myocardial infarction. of PGE2, prostacyclin, and TXA2 when stimulated with the chemotactic peptide n-formyl-methionyl-leucyl-phenylalanine (FMLP) or bradykinin (BK) relative to noninfarcted hearts (l) . Surprisingly, much of the enhanced prostanoid synthesis was shown to occur in the atria, a site remote from the zone of injury- (2) , and was associated with a 10-15-fold increase in atrial FMLP receptor number in the absence of atrial inflammation (Dunkel, C. G., J. E. Saffitz, and A. S. Evers. Submitted for publication.). Furthermore, when compared to noninfarcted control animals, the isolated perfused hearts of infarcted animals demonstrated an exaggerated FMLP-induced coronary vasoconstriction which was peptidoleukotriene-mediated and confined exclusively to the right atrium, as well as a BK-induced PG-mediated coronary vasodilation (1, 2) .
In these previous experiments, a temporal relationship was observed between enhanced eicosanoid synthesis and inflammatory cell influx into the infarct zone. We therefore hypothesized that leukocyte influx might be required for enhanced arachidonate metabolism after LVMI. Further support for the relationship between leukocyte invasion into injured tissue and exaggerated eicosanoid synthesis is found in previous work in the hydronephrotic kidney, a model of renal inflammation. In these studies, exaggerated renal eicosanoid production was suppressed when inflammatory cell influx was inhibited by nitrogen mustard treatment before unilateral ureteral obstruction (3) . Release of the ureteral obstruction also resulted in a rapid disappearance of inflammatory cells from the kidney and a return of eicosanoid production towards normal (4) .
To determine whether invading leukocytes mediate the LVMI-induced augmentation in eicosanoid production, acute inflammatory cell influx was suppressed either by inducing leukopenia with nitrogen mustard or by administration of BW-755C, a mixed cyclooxygenase-lipoxygenase inhibitor previously shown to inhibit inflammatory cell influx in canine LVMI (5) . These studies demonstrate that suppression of leukocyte invasion inhibits exaggerated cardiac and atrial eicosanoid production that follows LVMI and results in dramatic changes in coronary vascular reactivity.
Methods

Materials
Bradykinin was purchased from Boehringer-Mannheim (Indianapolis, IN), and A23 187, FMLP, and mechlorethamine were purchased from Sigma Chemical Co. (St. Louis, MO). Leukotriene 
Surgical myocardial infarction
Male New Zealand white rabbits (2-3 kg) were subjected to in vivo LVMI consisting of 60 min of left circumflex coronary artery occlusion followed by reperfusion as previously described (1) . Briefly, after pentobarbital anesthesia (35 mg/kg i.v.), a tracheostomy was performed, the rabbits were ventilated with 100% oxygen, and the hearts were exposed through a transverse thoracotomy. After pericardiotomy, a 5-0 Prolene suture was placed under the distal left circumflex coronary artery and tied over a piece of polyethylene tubing (PE-50; ClayAdams Div., Becton-Dickenson and Co., Parsippany, NJ) placed parallel to the vessel. Myocardial ischemia was evident upon tightening the ligature by the appearance of a wedge-shaped anemic zone. After 60 min reperfusion was achieved by sliding the PE-50 tubing from underneath the ligature, manifested by a cherry red hyperemia in the previously bland wedge of ischemic myocardium. The thoracotomy was then closed in layers, the tracheostomy repaired, and the animals allowed to convalesce.
Heart perfusion I or 2 d-after surgery, the animals were reanesthetized and heparinized (1,000 U i.v.). The hearts were excised and the aortas were quickly suspended from a perfusion apparatus. The aorta was then perfused in a retrograde fashion resulting in the delivery of oxygenated (02/CO2, 95%:5%) Krebs-Henseleit buffer (NaCl 120 mM, KC1 4.7 mM, MgSO4 1.2 mM, CaCl2 2.5 mM, KH2PO4 1.2 mM, NaHCO3 25 mM, dextrose 10 mM) at 370C and a constant flow rate of 25 ml/min to the coronary arteries. This promptly resulted in a spontaneously beating preparation with a mean basal coronary perfusion pressure of 50±6 mmHg. Changes in perfusion pressure were monitored via a sidearm in the perfusion apparatus using a pressure transducer (P23db; Statham, Inc., Oxnard, CA) and a brush recorder (model 440; Gould, Inc., Santa Clara, CA). After a 30-min equilibration period, cardiac effluent was collected for 5 min before and after stimulations with bolus intracoronary administration of FMLP (100 ng) or BK (1 ug) via an injection port 12 cm above the aorta. These doses were shown to elicit maximal eicosanoid production from infarcted hearts (1). A l-ml aliquot of effluent was stored at -20'C until quantitated for prostaglandins, thromboxane, and LTB4 by RIA, and the remainder of the collection sample was extracted for LTC4 as described below. Leukotrienes were not measured after bradykinin administration as previous studies failed to demonstrate stimulated release (1).
To prepare isolated atria, the heart was placed in iced Krebs-Henseleit buffer following cardiac perfusion. The atria were removed and suspended under 1 g of tension in a tissue bath containing 20 ml RIA RIA analyses of 6-keto-PGFl1 (a stable metabolite of prostacyclin), PGE2, and thromboxane B2 (a stable metabolite of TXA2) were performed as previously described (6, 7) . RIA for LTB4 (8) and LTC4 was performed as previously described. The cross-reactivities of the PGE2, 6-keto-PGFl1, TXB2, and LTC4 antisera have been previously described (1). Extraction of LTC4 for RIA consisted of applying the 125-ml sample (acidified to pH 6.2 with HCl) to a preactivated C-18 octadecylsilyl column (J. T. Baker Chemical Co., Phillipsburg, NJ).
The column was washed with water and the products were eluted with 5 ml of 100% methanol. Recovery, as determined from extractable [3H]LTC4 from 125 ml buffer samples, was 80±6% (n = 4).
Histology
After ex vivo cardiac perfusion experiments, transmural slices of the heart were prepared to include both infarcted and normal myocardium and then fixed in 10% phosphate-buffered formalin. Tissue was processed conventionally for light microscopy and sectioned at 5 Mm. Sections were stained with hematoxylin and eosin and examined by light microscopy. To determine the extent of inflammatory cell influx, multiple areas oftransmural sections were examined from two or more slices of at least three animals in control and experimental groups.
FMLP receptor binding studies I or 2 d after coronary artery occlusion, hearts from anesthetized and heparinized animals were removed and retrogradely perfused via an aortic cannula with 20 ml of ice-cold saline to remove blood from the vasculature. Atria were frozen over dry ice, sectioned at 12 Mim with a cryostat (-20'C), mounted on gelatin-coated slides and stored overnight at -20'C. Binding isotherms were performed by incubating tissue sections at 250C for 30 min in buffer containing increasing concentrations (0. 
Assessment ofin vivo cyclooxygenase and lipoxygenase inhibition
To validate the in vivo efficacy of BW-755C, a whole blood assay was performed to determine cyclooxygenase and lipoxygenase activity as previously described (9) . In brief, blood was drawn from the marginal ear vein ofeach animal before and after BW-755C administration. The sample was collected in a plastic test tube containing 0.1 volumes percent of heparin (1,000 U/ml) and placed in a water bath at 370C. After a 2-min equilibration period, the calcium ionophore A23 187 was added to the blood sample to stimulate eicosanoid production (final concentration 20 Mg/ml). After a 5-min stimulation, the reaction was terminated by centrifugation (3,000 g for 1 min), and the plasma was collected and stored at -20°C. Cyclooxygenase and lipoxygenase activity was estimated from TXB2 and LTB4 quantitation (RIA), respectively. Each experimental animal was subjected to stimulations before administration of BW-755C, and at 12 and 24 h after coronary reperfusion.
Guinea pig ileum assay
To demonstrate reversible inhibition of cardiac lipoxygenase by BW-755C, a guinea pig ileum strip was superfused by coronary venous effluent from an ex vivo buffer perfused rabbit heart to detect peptidoleukotrienes. Contractions were recorded in response to authentic LTD4 (standardization), FMLP, and BK administered directly to the tissue or through the heart in the presence of BW-755C or FPL-557 12, a peptidoleukotriene antagonist. To confirm the in vivo efficacy of mechlorethamine, total and differential leukocyte counts were performed before and after drug treatment. Nitrogen mustard administration resulted in a marked reduction in circulating leukocytes (control 5,760±700/mm3 of whole blood, n -5, vs. nitrogen mustard treatment 700±50/mm3, n = 4, P < 0.05) with PMN preferentially suppressed (PMN > 95% inhibition, mononuclear leukocytes 60%).
Histology. Histological analysis of control 2-d reperfused hearts previously subjected to 1 h ofdistal left circumflex coronary artery occlusion demonstrated transmural left ventricular myocardial infarction (Fig. 1 a) . Numerous inflammatory cells were seen throughout the infarcted tissue and consisted primarily of mononuclear cells (macrophages and lymphocytes) with PMNs occasionally observed. In contrast, the hearts of those animals treated with nitrogen mustard before surgical LVMI demonstrated a dramatic reduction in inflammatory cell influx. Despite large areas of transmural infarction, only rare mononuclear leukocytes or PMNs were observed in any experimental animal (Fig. 1 b) .
Eicosanoid production. Rendering animals leukopenic before surgical LVMI results in not only dramatic inhibition of inflammatory cell influx into the infarct zone, but also in marked suppression of agonist-stimulated eicosanoid production in cardiac perfusion experiments. As summarized in Table I , nitrogen mustard pretreatment resulted in greatly diminished FMLP-stimulated eicosanoid production measured from perfused hearts: PGE2 (73% reduction when compared to control hearts of 2-d infarcted animals), 6-keto-PGFla (67%), TXB2 (91%), and leukotrienes B4 (56%) and C4 (84%). Bradykinin-induced PGE2 and TXB2 production from nitrogen mustard treated animals were suppressed as well (56 and 84% reductions, respectively). These results were not due to toxic effects of nitrogen mustard, as mechlorethamine administration to nonoperated animals had no effect on agonist-stimulated cyclooxygenase or lipoxygenase product formation (data not shown).
Isolated atria. Previous work has demonstrated that the right atrium is responsible for much of the enhanced eicosanoid production after LVMI. In this regard, following LVMI, there was an approximately eight-fold increase in atrial TXB2 release (2) . In the current study, we therefore used TXB2 release from isolated atria as a marker for the exaggerated atrial eicosanoid synthesis after LVMI. As summarized in Table I , using isolated atria from animals treated with nitrogen mustard, FMLP and BK-induced TXB2 production was greatly diminished (79 and 72% reductions from control 2-d infarcts, respectively). It therefore appears that nitrogen mustard treatment not only suppresses total agonist-stimulated cardiac eicosanoid production, but specifically inhibits the exaggerated atrial eicosanoid production that follows LVMI.
Atrial FMLP receptor expression. Previously, it was demonstrated that the enhanced FMLP-stimulated atrial eicosanoid production after LVMI was associated with a marked increase in FMLP receptor number (Dunkel, C. G., J. E. Saffitz, and A. S. Evers. Submitted for publication.). To determine whether the decrease in atrial arachidonate metabolism following nitrogen mustard treatment was mediated by an alteration in FMLP receptor expression, binding studies were performed using 3H-FMLP. As seen in Table II the peptidoleukotriene antagonist FPL-55712 (0.4 qg/ml).
After discontinuing the BW-755C infusion, normal contractions in response to intracoronary FMLP were promptly restored, demonstrating rapid and complete washout of BW-755C from cardiac tissue. To validate the in vivo efficacy of BW-755C following its administration, the ability of A23187 to stimulate whole blood production of LTB4 and TXB2 was used to assess lipoxygenase and cyclooxygenase activity, respectively (Table III) . With each animal serving as its own control, BW-755C resulted in a > 70% reduction in LTB4 production and 55% reduction in TXB2 synthesis determined 12 and 24 h postcoronary reperfusion, demonstrating effective cyclooxygenase and lipoxygenase inhibition for the duration of the experiment.
Histology. Histological analysis of 1-d-infarcted rabbit hearts demonstrated transmural myocardial necrosis and prominent reperfusion changes. Inflammatory cell influx consisted almost exclusively of PMNs densely infiltrating infarcted tissue and frequently forming aggregates (Fig. 1 c) . In contrast, 1 d infarcted hearts from animals receiving BW-755C demonstrated a reduction of inflammatory cell influx into the zone of cardiac injury. PMNs were found sparsely infiltrating necrotic myocardium and rarely forming aggregates (Fig. 1 d) . These results are consistent with previous work using BW-755C at 5 h of reperfusion in experimental canine myocardial infarction (5 the attenuation of agonist-stimulated eicosanoid production after LVMI, eicosanoid production was quantitated (RIA) from isolated perfused hearts of BW-755C treated, l-d infarcted animals. As seen in Table I FMLP-stimulation of  PGE2, TXB2 , and LTB4 in animals treated with BW-755C was greatly diminished (69, 50, 83% reductions when compared to control l-d LVMI, respectively). Bradykinin administration to the hearts of BW-755C treated animals also resulted in greatly diminished production of PGE2 and TXB2 (66 and 56% reduction from controls, respectively). As in the nitrogen mustard experiments, isolated atria from hearts ofinfarcted rabbits treated with BW-755C demonstrated diminished production of FMLP and BK-induced TXB2 production (43 and 40% reductions from control l-d infarcts, respectively [ Table I ]).
Coronary resistance changes. As in the previous experiments, coronary perfusion pressure was recorded during agonist stimulations. Again, as was observed in the nitrogen mustard treated group, the hearts of animals treated with BW-755C demonstrated a reversal ofthe FMLP-induced coronary vasoconstriction and augmentation of the BK-induced coronary vasodilation seen after LVMI (Fig. 2) .
Enhanced leukotriene production from infarcted myocardium and its relationship to invading leukocytes. To determine whether infarcted myocardium is capable of exaggerated leukotriene biosynthesis, LTC4 and LTB4 production were quan-20 lo l3lz4L IU titated in 1-and 2-d myocardial infarcts. As seen in Table I , infarcted hearts show increases in basal and FMLP-stimulated LTB4 production, as well as in FMLP-stimulated LTC4 production. Peak release of LTB4 was temporally associated with maximal PMN infiltration into the infarct zone as assessed histologically (Fig. 4) . Also, exaggerated LTC4 production was found to occur at the time ofinitial macrophage influx (Fig. 4) .
Discussion
Contribution of invading leukocytes to myocardial infarction.
Previous work has shown that after in vivo rabbit LVMI, isolated perfused hearts demonstrate greatly exaggerated prostanoid production in response to stimulation with the chemotac- The mechanism of exaggerated atrial eicosanoid production in response to left ventricular ischemic injury is unknown. Unlike the damaged ventricle, there is no evidence ofhistological damage or of leukocyte invasion into the atria that exhibits the enhanced eicosanoid metabolite production. One possibility is that exaggerated atrial eicosanoid metabolite production (Table I) (1 1, 12) .
Role ofleukotrienes in myocardial infarction. Leukotriene production may have a deleterious effect on developing myocardial infarcts (10, 13) . The present study demonstrates that infarcted myocardium is capable of exaggerated LTC4 and LTB4 production (Fig. 4) . It appears that the macrophage is the principal cellular source of enhanced LTC4 production following LVMI. This is evidenced by the temporal relationship between macrophage accumulation histologically and the development of exaggerated LTC4 production 2 d after LVMI (Fig.  4) . Furthermore, previous studies have shown macrophages possess FMLP receptors (14) and have a prominent synthetic capacity for LTC4 production (15) . The (20) , and ulcerative colitis intestinal mucosa (21) . Also, in a model of acute inflammation in mice (intraperitoneal zymosan injection), a causal relationship between LTB4 production and PMN influx has been recently established (22 (Fig. 4) ; (c) in vivo inhibition of LTB4 production, as validated by a reduction in ionophore-stimulated whole blood synthesis of this eicosanoid in animals receiving BW-755C (Table III) is associated with a suppression of leukocyte invasion into infarcted myocardium. Furthermore, the concentration of LTB4 released into the coronary effluent from infarcted hearts has been previously shown to induce chemokinesis in rabbit PMNs (23 
